Asclemed USA Inc. recalls Lidocaine HCl Injection USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Lidocaine HCl Injection USP
- Company
- Asclemed USA Inc.
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- N/A
- About this recall
- Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.